1. W. Ke, L. Liu, J. Liu, A. Chen, W. Deng, P. Zhang, X. Cao, Z. Liao, H. Xiao, J. Liu, and Y. Li, “Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study,” Journal of Diabetes Research, vol. 2016, pp. 1–7, 2016.
2. Al-Awar
3. Y. Li, W. Xu, Z. Liao, B. Yao, X. Chen, Z. Huang, G. Hu, and J. Weng, “Induction of Long-term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients Is Associated With Improvement of -Cell Function,” Diabetes Care, vol. 27, no. 11, pp. 2597–2602, Oct. 2004.
4. Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., … & Ran, XEffect of intensive insulin therapy on B-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. The Lancet, vol. 37, no. 19626, pp. 1753–1760, 2008.
5. Hu, Y., Li, L., Xu, Y., Yu, T., Tong, G., Huang, H., … & Zhu, D. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and B-cell function in subjects with long-term remission. Diabetes care, vol. 34, no. 8, pp. 1848–1853, 2011.